The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 348:1925-1927 May 8, 2003 Number 19
NextNext

Multifactorial Intervention and Cardiovascular Disease in Type 2 Diabetes

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-Related Article
by Solomon, C. G.
-Related Article
by Gæde, P.
-PubMed Citation
To the Editor: Gæde et al. (Jan. 30 issue)1 unintentionally demonstrate that for many patients, treatment of type 2 diabetes amounts to benign neglect. This is illustrated by the absence of a meaningful reduction in glycosylated hemoglobin, total cholesterol, or systolic blood pressure in the conventionally treated group over the eight-year duration of the trial.

The management of many aspects of type 2 diabetes should be straightforward. For some time, effective drugs have been available, with strong evidence that should support their use.2,3,4 This information has been widely disseminated, particularly within the diabetes community. Yet in a country with universal . . . [Full Text of this Article]



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.